Maglangit, Marites G.

HRN: 06-02-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/15/2022
09/21/2022
IVT
500 Mg
Q8
Intestinal Amoebiasis
Waiting Final Action 
09/15/2022
CIPROFLOXACIN 500MG (TAB)
09/15/2022
09/21/2022
PO
500 Mg
Bid
Intestinal Amoebiasis, Uti,
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: